Combination of axitinib and dasatinib for anti-cancer activities in two prostate cancer cell lines

• मुख्य लेखकों: Nai-Xiong Peng (लेखक), Chun-Xiao Liu (लेखक), Xi-Sheng Wang (लेखक), Ze-Jian Zhang (लेखक), Su-Cai Liao (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Bangladesh Pharmacological Society, 2015-12-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Prostate cancer is the major cause of cancer-related deaths worldwide in men. There are new treatment methods and drugs are being developed with promising results in two of the prostate cancer cell lines (PPC-1 and TSU-Pr1). These two cells were treated with 20 uM of axitinib combined with dasatinib...